Oct 30 (Reuters) - Endo International Plc ENDP.O
* Endo announces certain preliminary financial results for third-quarter 2017 and affirms selected 2017 financial guidance
* Sees FY 2017 revenue $3.38 billion to $3.53 billion
* Q3 adjusted earnings per share $0.85 from continuing operations
* Q3 earnings per share view $0.66 -- Thomson Reuters I/B/E/S
* Endo International Plc - Sees Q3 revenues of approximately $785 million
* Q3 revenue view $784.9 million -- Thomson Reuters I/B/E/S
* FY2016 revenue view $3.92 billion -- Thomson Reuters I/B/E/S
* Endo International Plc - Expects 2017 adjusted EPS from continuing operations to be at upper end of guidance ranges of $3.35 to $3.65
* FY2017 earnings per share view $3.52, revenue view $3.47 billion -- Thomson Reuters I/B/E/S
* Endo International Plc - Qtrly preliminary reported (GAAP) loss per share from continuing operations of about $0.45
* Endo - "Unaware" of any unapproved, non-sterile-to-sterile compounding facilities currently selling/distributing Vasopressin injection product